Search Results 121-130 of 17259 for protein intake optimization

1. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... protein is detectable by serum protein ... All study participants must be registered into the mandatory ...

2. Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... Monoclonal protein in the serum or urine ... Requirement for concomitant high dose corticosteroids.

3. Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... Serum monoclonal protein (M-protein) ≥ 0.5 g/dL ... Hematologic function (requirement prior to first dose of ...

4. A Phase 2/3 Study To Investigate The Safety And Efficacy Of Brepocitinib In Adults With Lichen Planopilaris (ALPINE) - Mayo Clinic

   The purpose of this study is to determine the safety and efficacy of brepocitinib (a tyrosine kinase [TYK]2/Janus kinase [JAK]1 inhibitor) in adult participants ...

5. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma - Mayo Clinic

   Urine protein-to-creatinine ratio (UPCR) ≤ 1 mg/mg (≤ 113.2 mg/mmol) or 24-hour urine protein < 1 g. Reproductive Status. Female patients of childbearing ...

6. Analyzing the role of diet and exercise in myelin production - Mayo Clinic

   ... intake, exercise and myelin production in mice. ... protein (PLP) and myelin basic protein (MBP). ... High-fat diet alone or in combination with exercise has the ...

7. Enlarged prostate: Does diet play a role? - Mayo Clinic

   What type of protein you eat may matter. Some ... Experts recommend getting protein from plant sources, such as beans. ... Admissions Requirements · Degree Programs.

8. Laboratory Assay Optimization 2.0 - Clinical Trials

   The purpose of this study is to better understand the role of HIV and/or HCV infection and/or SARS-CoV-2 on the immune system and potential ways to eliminate ...

9. A Study of Atezolizumab Alone or Combined with Immunomodulatory Drug and/or Daratumumab in Multiple Myeloma Patients - Mayo Clinic

   Prior therapy with atezolizumab or other immunotherapies including CD137 agonists, anti-programmed death (PD)-1, anti-cytotoxic T-lymphocyte associated protein ...

10. Ajit H. Goenka, M.D. - Doctors and Medical Staff - Mayo Clinic

    2022. NIH R01 Award: Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein ... NIH R01 Award: Optimizing ... Admissions Requirements · Degree Programs · Student ...